GlassScriptPhysician profile
Seth G Derman
NPI 1093715161
$2,572.08
in general payments reported to CMS, 2019-2025
22 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $14.64 · 2021: $333 · 2022: $630 · 2023: $575 · 2024: $628 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $456.26 | 2021-2024 | Follistim Aq, Pregnyl, Ganirelix Acetate |
| Ferring Pharmaceuticals INC. | $413.59 | 2019-2025 | Menopur |
| Coopersurgical, INC. | $363.93 | 2022 | |
| Emd Serono, INC. | $346.54 | 2021-2024 | |
| Hologic Sales and Service, LLC | $257.04 | 2019-2024 | Acessa Provu System, Myosure Tissue Removal Device |
| Vertex Pharmaceuticals Incorporated | $120.36 | 2025 | |
| Roche Diagnostics Corporation | $106.08 | 2023 | Cobas 4800 Ct/Ng Test V2.0 |
| Viiv Healthcare Company | $105.44 | 2023 | Apretude |
| Myriad Women'S Health, INC. | $105.11 | 2023 | Genesight |
| Myovant Sciences INC. | $46.05 | 2021-2022 | |
| Therapeuticsmd, INC. | $42.75 | 2019 | |
| Merck Sharp & Dohme LLC | $33.13 | 2020-2021 | |
| Abbvie INC. | $25.15 | 2019 | |
| Hologic INC | $25.14 | 2021 | |
| Cook Medical LLC | $19.76 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtus Pharmaceuticals LLC | $17.27 | 2021 | |
| Agile Therapeutics, INC. | $17.03 | 2021 | |
| Minerva Surgical, INC | $16.30 | 2021 | |
| Genzyme Corporation | $14.43 | 2024 | |
| Celularity INC. | $14.00 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.76 | 2019 | |
| Exeltis, USA INC. | $12.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Derman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.